# Patient Reported Scale vs CTCAE Grading: A Prospective Comparator Study

> **NCT05158907** · NA · SUSPENDED · sponsor: **Tata Medical Center** · enrollment: 220 (estimated)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **OTHER:** Patient reported Adverse event scale

## Key facts

- **NCT ID:** NCT05158907
- **Lead sponsor:** Tata Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-11-23
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-02-28
- **Target enrollment:** 220 (ESTIMATED)
- **Why stopped:** Patient recruitment is slow
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05158907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05158907, "Patient Reported Scale vs CTCAE Grading: A Prospective Comparator Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05158907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*